Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice

被引:48
|
作者
Nicolas, L. [1 ,2 ]
Martinez, C. [3 ]
Baro, C. [4 ]
Rodriguez, M. [4 ]
Baroja-Mazo, A. [3 ]
Sole, F. [4 ]
Flores, J. M. [5 ]
Ampurdanes, C. [1 ]
Dantzer, F. [6 ]
Martin-Caballero, J. [1 ]
Aparicio, P. [2 ]
Yelamos, J. [1 ]
机构
[1] IMIM Hosp Mar, Barcelona Biomed Res Pk PRBB, Dept Immunol, Barcelona 08003, Spain
[2] Univ Murcia, Dept Biochem Mol Biol & Immunol, Sch Med, Murcia, Spain
[3] Univ Murcia, Dept Surg, CIBERehd, Univ Hosp Virgen de la Arrixaca, Murcia, Spain
[4] IMIM Hosp Mar, Barcelona Biomed Res Pk, Dept Pathol, Barcelona 08003, Spain
[5] Univ Complutense, Dept Anim Surg & Med, Sch Vet, E-28040 Madrid, Spain
[6] ESBS, IREBS FRE3211, Strasbourg, France
关键词
Parp-2; p53; tumour development; thymocytes; V(D)J recombination; double-strand breaks; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CHROMOSOMAL-ABERRATIONS; GENOMIC STABILITY; REPAIR; P53; RECOMBINATION; TUMORIGENESIS; INHIBITION; DEFICIENCY;
D O I
10.1038/onc.2010.11
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl) ation of proteins. Parp-2 deficiency in mice (Parp-2(-/-)) results in reduced thymic cellularity associated with increased apoptosis in thymocytes, defining Parp-2 as an important mediator of T-cell survival during thymopoiesis. To determine whether there is a link between Parp-2 and the p53 DNA-damage-dependent apoptotic response, we have generated Parp-2/p53-double-null mutant mice. We found that p53(-/-) backgrounds completely restored the survival and development of Parp-2(-/-) thymocytes. However, Parp-2-deficient thymocytes accumulated high levels of DNA double-strand breaks (DSB), independently of the p53 status, in line with a function of Parp-2 as a caretaker promoting genomic stability during thymocytes development. Although Parp-2(-/-) mice do not have spontaneous tumours, Parp-2 deficiency accelerated spontaneous tumour development in p53-null mice, mainly T-cell lymphomas. These data suggest a synergistic interaction between Parp-2 and p53 in tumour suppression through the role of Parp-2 in DNA-damage response and genome integrity surveillance, and point to the potential importance of examining human tumours for the status of both genes. Oncogene (2010) 29, 2877-2883; doi: 10.1038/onc.2010.11; published online 15 February 2010
引用
收藏
页码:2877 / 2883
页数:7
相关论文
共 50 条
  • [41] Ca2+-calmodulin antagonist chlorpromazine and poly(ADP-Ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of bcl-XL and p53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice
    Ray, SD
    Balasubramanian, G
    Bagchi, D
    Reddy, CS
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (03) : 277 - 291
  • [42] STUDY OF POLY(ADP-RIBOSE) POLYMERASES 1 AND 2 (PARP-1 AND PARP-2) IN INDUCED LYMPHOMAS IN P21 CIP1/WAF1 AND P-27 KIP2 MICE
    Flores, J. M.
    Garcia-Fernandez, R. A.
    Garcia-Palencia, P.
    Sanchez, M. A.
    Sanchez, B.
    Martin-Caballero, J.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2010, 143 (04) : 335 - 335
  • [43] Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate β-catenin and T-cell factor-4-mediated gene transactivation:: Possible linkage of DNA damage recognition and Wnt signaling
    Idogawa, Masashi
    Masutani, Mitsuko
    Shitashige, Miki
    Honda, Kazufumi
    Tokino, Takashi
    Shinomura, Yasuhisa
    Imai, Kohzoh
    Hirohashi, Setsuo
    Yamada, Tesshi
    CANCER RESEARCH, 2007, 67 (03) : 911 - 918
  • [44] Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor β chain and P53 double-knockout mice
    Kado, S
    Uchida, K
    Funabashi, H
    Iwata, S
    Nagata, Y
    Ando, M
    Onoue, M
    Matsuoka, Y
    Ohwaki, M
    Morotomi, M
    CANCER RESEARCH, 2001, 61 (06) : 2395 - 2398
  • [45] Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice -: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death
    Oumouna-Benachour, Karine
    Hans, Chetan P.
    Suzuki, Yasuhiro
    Naura, Amarjit
    Datta, Rahul
    Belmadani, Souad
    Fallon, Kenneth
    Woods, Cooper
    Boulares, A. Hamid
    CIRCULATION, 2007, 115 (18) : 2442 - 2450
  • [46] 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines
    Lin, Po-Hsiung
    Lin, Chia-Hua
    Huang, Chuan-Chen
    Chuang, Ming-Chien
    Lin, Pinpin
    TOXICOLOGY LETTERS, 2007, 172 (03) : 146 - 158
  • [47] LMO2 Overexpression and Loss of p19ARF Genetically Cooperate in the Development of T-Cell Acute Leukemia in Mice
    Treanor, Louise M.
    Zhou, Sheng
    Lu, Taihe
    Sorrentino, Brian P.
    MOLECULAR THERAPY, 2009, 17 : S290 - S290
  • [48] CELLULAR-REGULATION OF POLY ADP-RIBOSYLATION OF PROTEINS .2. AUGMENTATION OF POLY(ADP-RIBOSE) POLYMERASE IN SV40 3T3 CELLS FOLLOWING METHOTREXATE-INDUCED G1/S INHIBITION OF CELL-CYCLE PROGRESSION
    SOOKITOTH, A
    ASGHARI, F
    KIRSTEN, E
    KUN, E
    EXPERIMENTAL CELL RESEARCH, 1987, 170 (01) : 93 - 102
  • [49] Thieno[2,3-c]isoquinolin-5-one (TIQ-A), a Potent Poly(ADP-ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression In High Fat Diet-fed ApoE-deficient Mice: Effects on Inflammatory Markers and Lipid Content
    Hans, Chetan P.
    Zerfaoui, Mourad
    Naura, Amarjit
    Troxclair, Dana
    Strong, Jack P.
    Boulares, Hamid
    CIRCULATION, 2008, 118 (18) : S369 - S369
  • [50] Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content
    Hans, Chetan P.
    Zerfaoui, Mourad
    Naura, Amarjit S.
    Troxclair, Dana
    Strong, Jack P.
    Matrougui, Khalid
    Boulares, A. Hamid
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01): : 150 - 158